Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain

ClinicalTrials.gov ID: NCT00792727

Public ClinicalTrials.gov record NCT00792727. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Four-Week Study to Assess the Efficacy and Safety of HKT-500 in Subjects With Pain Caused by Mild to Moderate Osteoarthritis of the Knee

Study identification

NCT ID
NCT00792727
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hisamitsu Pharmaceutical Co., Inc.
Industry
Enrollment
380 participants

Conditions and interventions

Interventions

  • ketoprofen Patch Drug
  • Placebo Patch Other

Drug · Other

Eligibility (public fields only)

Age range
45 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2007
Primary completion
Mar 31, 2008
Completion
Apr 30, 2008
Last update posted
Jun 3, 2015

2007 – 2008

United States locations

U.S. sites
36
U.S. states
21
U.S. cities
34
Facility City State ZIP Site status
Hisamitsu Investigator Site Birmingham Alabama 35242
Hisamitsu Investigator Site Chandler Arizona 85225
Hisamitsu Investigator Site Peoria Arizona 85381
Hisamitsu Investigator Site San Diego California 92108
Hisamitsu Investigator Site Colorado Springs Colorado 80910
Hisamitsu Investigator Site Denver Colorado 80204
Hisamitsu Investigator Site Denver Colorado 80209
Hisamitsu Investigator Site Daytona Beach Florida 32117
Hisamitsu Investigator Site Delray Beach Florida 33484
Hisamitsu Investigator Site Fort Myers Florida 33916
Hisamitsu Investigator Site Pembroke Pines Florida 33024
Hisamitsu Investigator Site Evansville Indiana 47714
Hisamitsu Investigator Site Crestview Hills Kentucky 41017
Hisamitsu Investigator Site Fall River Massachusetts 02720
Hisamitsu Investigator Site Omaha Nebraska 68114
Hisamitsu Investigator Site Las Vegas Nevada 89104
Hisamitsu Investigator Site Reno Nevada 89502
Hisamitsu Investigator Site Albuquerque New Mexico 87102
Hisamitsu Investigator Site Greensboro North Carolina 27401
Hisamitsu Investigator Site Bismarck North Dakota 58503
Hisamitsu Investigator Site Cincinnati Ohio 45227
Hisamitsu Investigator Site Columbus Ohio 43212
Hisamitsu Investigator Site Mogadore Ohio 44260
Hisamitsu Investigator Site Zanesville Ohio 43701
Hisamitsu Investigator Site Oklahoma City Oklahoma 73109
Hisamitsu Investigator Site Tulsa Oklahoma 74136
Hisamitsu Investigator Site Warwick Rhode Island 02886
Hisamitsu Investigator Site Anderson South Carolina 29621
Hisamitsu Investigator Site Austin Texas 78752
Hisamitsu Investigator Site San Antonio Texas 78217
Hisamitsu Investigator Site San Antonio Texas 78232
Hisamitsu Investigator Site Salt Lake City Utah 84107
Hisamitsu Investigator Site Arlington Virginia 22205
Hisamitsu Investigator Site Charlottesville Virginia 22911
Hisamitsu Investigator Site Newport News Virginia 23606
Hisamitsu Investigator Site Yakima Washington 98902

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00792727, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 3, 2015 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00792727 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →